Dr. Greiwe is a consultant for AstraZeneca on social media and respiratory biologics scientific expert on the virtual advisory board; Sanofi Grenzyme Dupixent scientific expert on the virtual advisory board; honoraria from AstraZeneca Fesenra Speakers Bureau, Regeneron, and Sanofi Grenzyme Dupixent Speakers Bureau. Dr. Nyenhuis is a board member of Chicago Asthma Consortium; grant from National Institute of Health, honoraria from Sanofi, royalties from Springer Nature and Wolters Kluwer Health.